Laboratory investigations | Patients without risk factors cryptogenic (A1) (n = 37) | Patients with risk factors (A2) (n = 23) | Controls (healthy) (n = 60) | Test value | p-value | Post hoc between group A1 and A2 | |
---|---|---|---|---|---|---|---|
HB (g/dl) | Mean ± SD | 12.8 ± 1.5 | 12.3 ± 2.7 | 12.6 ± 1.8 | F = 0.238 | 0.78 | 0.97 |
Range | 9.5–16.2 | 8.2–16.5 | 9.2–16.1 | ||||
WBC X 103/μL | Mean ± SD | 7.94 ± 7.94 | 8.43 ± 3.3 | 6.26 ± 2.0 | F = 8.87 | < 0.001* | 0.74 |
Range | 3.77–13.5 | 4.5–16.75 | 4.32–10 | ||||
PLTs X103/μL | Mean ± SD | 264 ± 78.645 | 270 ± 101.89 | 241 ± 92.82 | F = 1.21 | 0.30 | 0.964 |
Range | 130–446 | 95–493 | 493–600 | ||||
MPV (fl) | Mean ± SD | 10.6 ± 1.5 | 10.9 ± 1.6 | 9.3 ± 1.7 | F = 11.81 | < 0.001* | 0.781 |
Range | 8.5–14.2 | 8.4–14.5 | 6.0–12.9 | ||||
PDW (fl) | Mean ± SD | 13.6 ± 2.9 | 13.5 ± 1.9 | 11.9 ± 1.9 | F = 8.75 | < 0.001* | 0.6124 |
Range | 9.5–22 | 10.5–16.9 | 9.4–20.7 | ||||
L-PCR (%) | Mean ± SD | 29.4 ± 5.1 | 26.4 ± 4.9 | 28.9 ± 6.1 | F = 2.14 | 0.542 | 0.12 |
Range | 15.4–38.1 | 19.5–41.9 | 18.4–47.9 |